Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 36Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Depakine

PharmaCompass

01

Brand Name : Depakine

arrow
PPS Boston
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Divalproex Sodium

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : -2.50%

2013 Revenue in Millions :

Growth (%) :

Sanofi Company Banner

02

Brand Name : Depakine

arrow
PPS Boston
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Divalproex Sodium

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 435

2014 Revenue in Millions : 464

Growth (%) : 7%

Sanofi Company Banner

03

Brand Name : Depakine

arrow
PPS Boston
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Divalproex Sodium

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 441

2015 Revenue in Millions : 447

Growth (%) : -1

Sanofi Company Banner

04

Brand Name : Depakine

arrow
PPS Boston
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Divalproex Sodium

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 549

2016 Revenue in Millions : 516

Growth (%) : 6

Sanofi Company Banner

05

Brand Name : Depakine

arrow
PPS Boston
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Divalproex Sodium

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 511

2017 Revenue in Millions : 501

Growth (%) : 2%

Sanofi Company Banner